SYNLOGIC, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
SYNLOGIC, INC. (SYBX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 302.04 thousand shares for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-04.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2017-08-04
- SYNLOGIC, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2017-06-30 was 23.45K shares.
- SYNLOGIC, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2017-03-31 was 278.59K shares.
- SYNLOGIC, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2016-09-30 was 56.58K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month |
|---|---|---|---|
| 2017-06-30 | 23.45K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | 302.04K shares 10-Q · filed 2017-08-04 | |
| 2017-03-31 | 278.59K shares 10-Q · filed 2017-05-09 | ||
| 2016-09-30 | 56.58K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 350.43K shares 10-Q · filed 2016-11-10 | |
| 2016-06-30 | 293.85K shares 10-Q · filed 2016-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |